AFJK vs BTBT

Bit Digital, Inc.

(BTBT) offers the better valuation at 9. 2x trailing P/E, making it the more compelling value choice. Analysts rate Bit Digital, Inc. (BTBT) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Bit Digital, Inc.

(BTBT) is the cheapest at 9. 2x versus Aimei Health Technology Co. , Ltd at 251. 0x.

Over the past 5 years, Aimei Health Technology Co.

, Ltd (AFJK) delivered a total return of +320. 4%, compared to -84. 6% for Bit Digital, Inc. (BTBT). Over 10 years, the gap is even starker: AFJK returned +320. 4% versus BTBT's -60. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Aimei Health Technology Co.

, Ltd (AFJK) is the lower-risk stock at 0. 23β versus Bit Digital, Inc. 's 3. 37β — meaning BTBT is approximately 1343% more volatile than AFJK relative to the S&P 500. On balance sheet safety, Bit Digital, Inc. (BTBT) carries a lower debt/equity ratio of 3% versus 25% for Aimei Health Technology Co. , Ltd — giving it more financial flexibility in a downturn.

On earnings-per-share growth, the picture is similar: Bit Digital, Inc.

grew EPS 225. 0% year-over-year, compared to -39. 3% for Aimei Health Technology Co. , Ltd. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Bit Digital, Inc.

(BTBT) is the more profitable company, earning 17. 3% net margin versus 0. 0% for Aimei Health Technology Co. , Ltd — meaning it keeps 17. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BTBT leads at 16. 8% versus 0. 0% for AFJK. At the gross margin level — before operating expenses — BTBT leads at 61. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, BTBT (0.

3% yield) pays a dividend. AFJK does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Aimei Health Technology Co.

, Ltd (AFJK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), +320. 4% 10Y return). Bit Digital, Inc. (BTBT) carries a higher beta of 3. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AFJK: +320. 4%, BTBT: -60. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AFJK is a small-cap quality compounder stock; BTBT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.